NetEase Inc vs Tilray Brands Inc — how do they compare? NetEase Inc trades at $124.8 (market cap $76.09B), while Tilray Brands Inc trades at $3.49 (market cap $530.54M). The key difference: NetEase Inc is far larger — about 143.4× Tilray Brands Inc's market cap, and NetEase Inc pays a 2.45% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold NetEase Inc for 74 Days and Tilray Brands Inc for 31 Days on average.
| NTES | TLRY | |
|---|---|---|
Market Cap | $76.09B | $530.54M |
Volume | 486,447 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $152.85 | $21.00 |
52-Week Low | $109.26 | $3.57 |
Typical Hold Time | 74 Days | 31 Days |
Enterprise Value | $51.81B | $684.46M |
Dividend Yield | 2.45% | — |
Signals from Pluang's Aura AI — not financial advice
NetEase (NTES) trades at $120.61, up 1.29% with mixed technical signals showing neutral momentum. The company demonstrates strong fundamentals with $112.63B revenue and 27.88% net margin in 2025, though recent quarterly earnings show volatility with two misses in the last three quarters. Analyst consensus remains strongly bullish with 82% buy ratings and a $168 price target representing 39% upside potential.
The investment case balances strong profitability and cash generation against earnings volatility and competitive pressures. Key opportunities include consistent revenue growth and attractive valuation multiples, while risks center on gaming market competition and China regulatory environment. The stock presents value for long-term investors given the significant discount to analyst targets.
TLRY trades at $3.465, down 6.73% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows weak technical momentum with oversold RSI readings but faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins, and declining revenue growth. Recent news highlights the company's struggles with profitability despite record annual revenue, with shares down over 50% year-to-date as investors question the cannabis company's path to sustainable growth.
TLRY presents a high-risk opportunity with significant downside protection from its low P/B ratio of 0.33, but requires substantial operational improvement to justify investment. The bullish case hinges on potential marijuana reform catalysts and BrewDog integration progress, while risks include ongoing losses, competitive pressures, and execution challenges in a volatile regulatory environment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →